AUS
NZ
UK
CA
USA
IND
Healthcare
ASX 200 Healthcare Shock: ASX:CBA Supports Healthscope Amid Receivership
May 26, 2025 02:49 PM AEST| By Team Kalkine MediaHighlights,Healthscope enters voluntary receivership amid severe financial strain and debt concerns,Commonwealth Bank of Australia (ASX:CBA) offers financial support to maintain hospital operations,Landlords issue breach notices as tenancy defaults e...
Recce Pharmaceuticals (ASX:RCE) Strengthens Patent Portfolio with Chinese Approval, Boosting Presence in ASX200 Pharma Sector
May 26, 2025 12:57 PM AEST| By Team Kalkine MediaHighlights,Recce secures patent approval in China for key anti-infective drug candidates.,Patent covers multiple bacterial and viral infections with varied administration methods.,Expansion enhances Recce’s global intellectual property footprint in m...
Which Healthcare Leader in the S&P/ASX Two Hundred and ASX All Ordinaries Tops Global Fund Holdings?
May 23, 2025 06:18 PM AEST| By Team Kalkine MediaWhich Healthcare Leader in the S&P/ASX Two Hundred and ASX All Ordinaries Tops Global Fund Holdings?
ASX 200 Health Stocks Climb Amid Capital Raisings and Diagnostic Advancements
May 23, 2025 04:31 PM AEST| By Team Kalkine MediaHighlights:,Multiple ASX-listed healthcare firms initiate capital raisings to strengthen cash positions,EMVision showcases improved stroke diagnostic performance using AI at major health conference,Monash IVF updates FY25 outlook following operationa...
Mayne Pharma (ASX:MYX) Shares Show Partial Rebound Amid Takeover Uncertainty and ASX200 Volatility
May 23, 2025 02:41 PM AEST| By Team Kalkine MediaHighlights,Mayne Pharma shares recover after sharp weekly decline,FDA concerns impact takeover negotiations with US firm Cosette,Market watchers eye implications for ASX dividend stocks and ASX200,Mayne Pharma (ASX:MYX) shares experienced a partial r...
Hengrui’s Soaring Hong Kong Debut Sparks Optimism Across ASX200 and Global Pharma Markets
May 23, 2025 12:27 PM AEST| By Team Kalkine MediaHighlights,Hengrui jumps 29% in Hong Kong listing,$2 billion capital to fuel drug innovation,Market buzz adds momentum to ASX200,In a remarkable debut that has stirred enthusiasm among global investors,,Jiangsu Hengrui Pharmaceuticals (HKG:600276),,...
Nyrada’s Breakthrough TRPC Blocker Gains Momentum in ASX200 Medical Research Space
May 23, 2025 12:00 AM AEST| By Team Kalkine MediaHighlights,Drug shows promise for stroke, heart attack, and brain injury,Early trial data confirms safety and strong tissue preservation,Anti-arrhythmic effects observed in follow-up studies,Nyrada Inc. (ASX:NYR) has reported encouraging progress on...
Regeneron (NASDAQ:REGN) Moves to Acquire 23andMe Amid Market Shifts — What ASX200 Investors Should Know
May 23, 2025 12:00 AM AEST| By Team Kalkine MediaHighlights,Regeneron to acquire 23andMe’s core assets for $256 million,Customer DNA data security prioritized in the deal,Acquisition aligns with growing biotech innovation in ASX200 and beyond,Biotechnology leader Regeneron Pharmaceuticals (NASDAQ:R...
Could Mayne Pharma’s Deal Review Rattle ASX 200 and Health Care Index?
May 22, 2025 03:30 PM AEST| By Team Kalkine MediaCould Mayne Pharma’s Deal Review Rattle ASX 200 and Health Care Index?
Mayne Pharma Shares Hit New Low as ASX200 Pressure Mounts
May 22, 2025 01:42 PM AEST| By Team Kalkine MediaHighlights,Mayne Pharma faces steep decline amid investor uncertainty,FDA letter adds pressure as Cosette Pharmaceuticals reconsiders deal,Shares down over 39% since April peak,Mayne Pharma (ASX:MYX) continues to face headwinds as its shares hit fres...
Could AFT Pharmaceuticals Boost ASX and S&P Health Care Index Momentum?
May 22, 2025 10:30 AM AEST| By Team Kalkine MediaCould AFT Pharmaceuticals Boost ASX and S&P Health Care Index Momentum?
Pro Medicus (ASX:PME) Surges in ASX300: Exploring Healthcare Tech’s Strong Momentum
May 21, 2025 01:49 PM AEST| By Team Kalkine MediaHighlights,Pro Medicus sees double-digit growth in early 2025,Healthcare tech shines amid global sector momentum,PME valuation reflects rising demand for radiology software,Pro Medicus Ltd (ASX:PME), a leading name in medical imaging software, has co...
ASX 200 Financial Sector Watch: CBA, MYX, ADT in Spotlight Amid Index Fluctuations
May 21, 2025 01:30 PM AEST| By Team Kalkine MediaHighlights:,Commonwealth Bank (ASX:CBA) reaches a historic intraday high despite market uncertainties,Mayne Pharma (ASX:MYX) experiences steep decline following takeover withdrawal,Adriatic Metals (ASX:ADT) records share surge amid acquisition intere...
ASX200 Update: Nanosonics (ASX:NAN) Shares Climb Amid Market Query
May 21, 2025 12:47 PM AEST| By Team Kalkine MediaHighlights,Nanosonics,shares rise after addressing ASX query,Company unaware of reasons behind unusual trading activity,Previous,share movement linked to FDA approval in March,Shares of medical device firm Nanosonics (ASX:NAN) saw a notable rebound a...
ASX200 M&A Drama: Why Cosette Abandoned Its $672M Mayne Pharma Deal
May 21, 2025 12:40 PM AEST| By Team Kalkine MediaHighlights,Private equity bidder Cosette exits deal citing earnings and regulatory issues,Mayne Pharma's (MYX) stock tumbles 30% amid legal tussle,Market volatility, earnings downgrade, and FDA scrutiny shake confidence,In a dramatic turn of events t...
Debt Monitoring in Focus: Monash IVF Group (ASX:MVF) Navigates Liabilities on the ASX 200
May 21, 2025 12:33 PM AEST| By Team Kalkine MediaHighlights,Monash IVF Group (ASX:MVF) shows disciplined debt handling with increasing earnings,Free cash flow trends underline the company's financial management strategy,Rising net debt warrants close attention within broader balance sheet metrics,M...
ASX200 Biotech Watch: Mayne Pharma (ASX:MYX) Shares Sink as Cosette Flags Deal Risk
May 21, 2025 11:51 AM AEST| By Team Kalkine MediaHighlights,Mayne Pharma shares dropped,nearly 30%,amid acquisition uncertainty,Cosette Pharmaceuticals raises concerns over financial and legal issues,Potential impact on ASX200 biotech sector and investor sentiment,Mayne Pharma Group (ASX:MYX) saw i...
Cosette Flags Concerns Over Mayne Pharma Takeover Amid ASX200 Market Movements
May 21, 2025 10:55 AM AEST| By Team Kalkine MediaHighlights,Cosette questions Mayne Pharma’s financial stability,FDA letter raises issues over contraceptive product marketing,Mayne Pharma defends transparency and rejects change claims,In a development stirring interest among investors tracking the,...
Breakthrough Osteoarthritis Therapy by Paradigm Biopharmaceuticals (ASX:PAR) Sets New Benchmark on ASX 200
May 21, 2025 09:30 AM AEST| By Team Kalkine MediaHighlights:,Paradigm Biopharmaceuticals (ASX:PAR) is developing Zilosul, a PPS-based drug, to address osteoarthritis,Clinical trials show extended symptom relief and improved joint function,Exclusive partnership with bene pharmaChem strengthens manuf...
Is Sonic Healthcare (ASX:SHL) Undervalued in 2025? ASX 200 Healthcare Stock Review
May 20, 2025 06:01 PM AEST| By Team Kalkine MediaHighlights,Sonic Healthcare Ltd (ASX:SHL) operates across diagnostics and pathology sectors globally,The company’s key financial indicators show mixed performance trends in recent years,Shares are currently trading below their long-term average valua...
Advertise your brand on Kalkine Media